Cargando…

Utility of Serum 1,3-β-d-Glucan Testing for Diagnosis and Prognostication in COVID-19-Associated Pulmonary Aspergillosis

Detalles Bibliográficos
Autores principales:	Egger, Matthias, Prüller, Florian, Krause, Robert, Prattes, Juergen, Hoenigl, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241918/ https://www.ncbi.nlm.nih.gov/pubmed/35638833 http://dx.doi.org/10.1128/spectrum.01373-22

Ejemplares similares

Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis
por: Hoenigl, Martin, et al.
Publicado: (2023)

Serum 1,3-Beta-D-Glucan Values During and After Laparoscopic and Open Intestinal Surgery
por: Szyszkowitz, Alexander, et al.
Publicado: (2018)

Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two‐centre mixed cohort study
por: Hoenigl, Martin, et al.
Publicado: (2021)

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
por: Prattes, Juergen, et al.
Publicado: (2021)

Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study
por: Autier, Brice, et al.
Publicado: (2022)

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
por: Hatzl, Stefan, et al.
Publicado: (2021)

Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report
por: Prattes, Juergen, et al.
Publicado: (2020)

The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update
por: Jenks, Jeffrey D., et al.
Publicado: (2020)

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
por: Jenks, Jeffrey D, et al.
Publicado: (2018)

Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
por: Lamoth, Frédéric
Publicado: (2016)

Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
por: Egger, Matthias, et al.
Publicado: (2022)

Blood Aspergillus PCR: The Good, the Bad, and the Ugly
por: Egger, Matthias, et al.
Publicado: (2020)

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection
por: Rabensteiner, Jasmin, et al.
Publicado: (2016)

2567. Diagnosis of Invasive Aspergillosis in Hematological Malignancy Patients Receiving Mold-Active Antifungals: Performance of Interleukin-6 and -8, Asp LFD, and Aspergillus PCR in Same-day Blood and Bronchoalveolar Lavage Fluid Samples
por: Hoenigl, Martin, et al.
Publicado: (2018)

Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations
por: Egger, Matthias, et al.
Publicado: (2023)

Aspergillus fumigatus and Its Allergenic Ribotoxin Asp f I: Old Enemies but New Opportunities for Urine-Based Detection of Invasive Pulmonary Aspergillosis Using Lateral-Flow Technology
por: Davies, Genna, et al.
Publicado: (2020)

Bronchoalveolar lavage fluid and serum 1,3-β-d-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance
por: Weinbergerova, Barbora, et al.
Publicado: (2020)

Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection
por: Rawlings, Stephen A., et al.
Publicado: (2019)

Performance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia
por: Koc, Özlem, et al.
Publicado: (2022)

Comparison of β-D-Glucan and Galactomannan in Serum for Detection of Invasive Aspergillosis: Retrospective Analysis with Focus on Early Diagnosis
por: Dichtl, Karl, et al.
Publicado: (2020)

Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis
por: Dai, Zhang, et al.
Publicado: (2021)

Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
por: Salzer, Helmut J. F., et al.
Publicado: (2018)

Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients
por: Eigl, Susanne, et al.
Publicado: (2015)

Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading
por: Boyer, Johannes, et al.
Publicado: (2023)

1462 Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis in ICU patients: a multicenter study
por: Hoenigl, Martin, et al.
Publicado: (2014)

Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
por: Prattes, Juergen, et al.
Publicado: (2021)

Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy
por: Zurl, Christoph, et al.
Publicado: (2021)

Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?
por: Prattes, Juergen, et al.
Publicado: (2016)

Variable Correlation between Bronchoalveolar Lavage Fluid Fungal Load and Serum-(1,3)-β-d-Glucan in Patients with Pneumocystosis—A Multicenter ECMM Excellence Center Study
por: Mercier, Toine, et al.
Publicado: (2020)

Serum 1,3-βD-Glucan assay in the diagnosis of invasive fungal disease in neonates
por: Mackay, Cheryl Anne, et al.
Publicado: (2011)

COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses
por: Mead, Matthew E., et al.
Publicado: (2023)

Treatment of Aspergillosis
por: Jenks, Jeffrey D., et al.
Publicado: (2018)

Elevated serum β-d-glucan levels in cavitary pulmonary nocardiosis
por: Yagyu, Kyoko, et al.
Publicado: (2020)

Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy
por: Honore, Patrick M., et al.
Publicado: (2020)

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020)

Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
por: Heldt, Sven, et al.
Publicado: (2017)

Editorial: Diagnostic Approaches for Aspergillus Infections
por: Salzer, Helmut J. F., et al.
Publicado: (2019)

Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis
por: Nuh, Ali, et al.
Publicado: (2022)

93. A Diagnostic Stewardship Intervention to Improve Utilization of 1,3-β-D-glucan Testing
por: Kendall, Jonathan A, et al.
Publicado: (2020)

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
por: Hoenigl, Martin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qgrgume55fsqbucg3dijcbt87s